![Galaxy Carton Renders](https://rayner.com/wp-content/uploads/2024/08/Galaxy-Carton-Renders-384x221.png)
Rayner announces launch of world’s first spiral IOL designed with AI
Posted on 27/08/2024
Rayner, a global manufacturer of products for cataract surgery based in Worthing, UK, today announces the upcoming launch of the world’s first spiral IOL designed with artificial intelligence: RayOne Galaxy and Galaxy Toric.
Launching at this year’s ESCRS Congress in Barcelona, the RayOne Galaxy IOL comes to market precisely 75 years after Rayner pioneered the very first IOL with Sir Harold Ridley, a milestone being celebrated throughout 2024. As in 1949, Rayner has partnered with a leading ophthalmologist, Dr João Lyra from Brazil, to develop this innovative full range of vision IOL.
Unlike in 1949, a proprietary AI engine trained on patient outcomes has been utilised to help create RayOne Galaxy’s unique spiral, which delivers a continuous full range of vision with minimised dysphotopsia, achieved through a non-diffractive optic with 0% light loss. RayOne Galaxy will be available immediately in toric powers and comes fully preloaded across the entire power range in the same single-use injector system as the rest of the popular RayOne family of lenses.
Tim Clover, Rayner CEO, said:
“We all read about the life changing potential of AI, but this is a real-world example of technology impacting the outcomes of patients. RayOne Galaxy represents a next generation technology in intraocular lenses to enable patients to see without spectacles. Launching the world’s first spiral optic lens on the 75th anniversary of the world’s first IOL feels poetic and I’m proud that Rayner is still at the forefront of technology, partnering with innovative surgeons from all over the world and making a difference to the life of millions of patients every year.”
Clinical investigations with RayOne Galaxy began earlier this year, in collaboration with 8 leading surgeons from around the world and key research labs in Europe and Brazil. Many of those surgeons are due to present their initial findings at the ESCRS 2024 meeting in September, at Rayner’s highly anticipated Sunday lunchtime symposium.
Mr Allon Barsam, Consultant Ophthalmic Surgeon and Director at OCL Vision in London, explained:
“The first patients received RayOne Galaxy at OCL Vision in July and their feedback so far has been overwhelmingly positive, with patients reading without glasses and thrilled with their quality of vision. I am proud to be participating in the first RayOne Galaxy study to provide my patients with the most advanced lens technology.”
END
About Rayner:
Since the implantation of the first Rayner intraocular lens by Sir Harold Ridley 1949, Rayner has the goal to improve vision and restore sight worldwide. Today, Rayner’s mission remains to deliver innovative and clinically superior ophthalmic products that respond to the expectations of our global customers to improve the sight and quality of life of their patients.
Headquartered in Worthing, United Kingdom, Rayner markets its medical devices, pharmaceuticals, and digital solutions worldwide in over 80 countries through a network of distributors and includes direct sales teams in the United Kingdom, Eire, USA, Canada, Brazil, India, Poland, Australia, Germany, Austria, Switzerland, France, Italy, Spain, and Portugal.
Not all Rayner products are approved for sale in every country. Please contact your local Rayner distributor for details of which products are available in your area.
©2024 Rayner Group, all rights reserved. ‘Rayner’, ‘RayOne’ and ‘Galaxy’ are proprietary marks of the Rayner Group. All other trademarks are property of their respective owners.
Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ | EC 2024-145